Up, Up, and Away
A business analyst rated Baxter stock a strong BUY, as the PD market has an attractive growth rate in the range of 5% to 6%, and the option is flexible and allows a more normal life.
Read the full article » | Posted 07-14-2017
Related Articles
- Telemedicine Can Help Grow Home Dialysis, Reduce Dropout, and Improve Outcomes Posted 03-15-2024
- Baxter Runs a Webinar Series Every Tuesday for Kidney Month Posted 03-15-2024
- Nephrologists: Sign Up for Home Dialysis University in February or March Posted 02-07-2024
- Minimally-invasive Hernia Repair for PD Posted 01-17-2024